论文部分内容阅读
目的观察低分子肝素治疗不同类型脑血栓的临床效果。方法选取医院收治的不同类型的脑血栓患者60例为研究对象,随机分为观察组和对照组,每组30例。对照组采用常规治疗,观察组在常规治疗的基础上采用低分子肝素治疗,比较2组患者前后神经功能缺损评分(NIHSS)及临床治疗效果。结果治疗后,观察组神经功能评分优于对照组(P<0.05);观察组总有效率为90.0%,高于对照组的70.0%(P<0.05)。结论低分子肝素对不同类型的脑血栓患者均有较好的疗效,能达到降低神经功能损伤的目的且对疾病治疗效果明确,值得临床推广应用。
Objective To observe the clinical effect of low molecular weight heparin on different types of cerebral thrombosis. Methods Sixty patients with different types of cerebral thrombosis admitted to hospital were selected as study subjects and randomly divided into observation group and control group with 30 cases in each group. The control group was treated with conventional therapy. The observation group was treated with low molecular weight heparin on the basis of routine treatment. The neurological deficit scores (NIHSS) and clinical outcomes of the two groups were compared. Results After treatment, the score of neurological function in the observation group was better than that in the control group (P <0.05). The total effective rate in the observation group was 90.0%, which was higher than that in the control group (70.0%, P <0.05). Conclusion Low molecular weight heparin has better curative effect on different types of patients with cerebral thrombosis, can achieve the purpose of reducing the nerve function damage and has a clear therapeutic effect on the disease, which is worthy of clinical application.